Koers Syneos Health, Inc.
Aandelen
SYNH
US87166B1026
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Colin Shannon
CEO | Chief Executive Officer | 65 | 28-09-23 |
Michael Bonello
DFI | Director of Finance/CFO | 55 | 01-07-23 |
Michael Brooks
COO | Chief Operating Officer | 50 | 14-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 28-09-23 |
Colin Shannon
CEO | Chief Executive Officer | 65 | 28-09-23 |
James Dimitri
BRD | Director/Board Member | - | 28-09-23 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.82% | 8 M€ | 0,00% | ||
0.77% | 2 M€ | +5,19% | ||
0.50% | 0 M€ | 0,00% | - | |
0.36% | 0 M€ | 0,00% | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,12% | 42,59 mld. | |
+6,77% | 40,65 mld. | |
+45,26% | 40,57 mld. | |
-11,96% | 26,77 mld. | |
+6,01% | 24,81 mld. | |
-24,92% | 18,17 mld. | |
-3,63% | 11,7 mld. | |
+27,16% | 12,05 mld. | |
+7,30% | 11,1 mld. |